Explore comprehensive CDMO services offered by Hepalink Group, supporting end-to-end Manufacturing. Hepalink Group enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: China
Description: Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is a Chinese biopharmaceutical company that is a global leader in the heparin industry, known for producing heparin sodium API and enoxaparin sodium injections. The company is also involved in the development and commercialization of innovative drugs and provides Contract Development and Manufacturing Organization (CDMO) services. Hepalink has a diverse pipeline of drug candidates for various diseases and is dual-listed on stock exchanges in Hong Kong and mainland China.
